Loading clinical trials...

Home Pulmonary Rehabilitation for COPD | Clinical Trials | Clareo Health

COMPLETEDNA

Home Pulmonary Rehabilitation for COPD

NCT03480386•Mayo Clinic

Summary

Regular physical activity has been found to be important in maintaining health and well-being in people with COPD. The purpose of this study is to test new technology and health coaching aimed to help people with COPD become more physically active in their daily lives.

Eligibility

Age

40 - 99 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Clinical diagnosis of COPD, confirmed by spirometry
•Age ≥40 years (to avoid recruiting participants with asthma rather than COPD)
•Current or previous smoker (≥10 packs per year)
•Confidence in using the proposed pulmonary rehabilitation (PR) system
•English language fluency

Exclusion Criteria

•Study candidate experiencing an acute COPD exacerbation (can be included after the acute event)
•Inability to walk (orthopedic-neurologic problems or confined to a bed)
•Currently in PR or finished PR in the last three months (unlikely to improve)
•Pregnant women
•Live in an area where cell phones do not work/

Locations (3)

Mayo Clinic in Florida

Jacksonville, Florida, United States

Health Partners

Minneapolis, Minnesota, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

January 1, 2019

Primary Completion Date

February 16, 2022

Completion Date

February 16, 2022

Last Updated

February 13, 2024

Enrollment

375

ACTUAL participants

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Emphysema

Interventions

Home Based Pulmonary Rehabilitation

BEHAVIORAL

cfMSC Stem Cell Therapy Targeting COPD

NCT07477600

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGNA

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

NCT07382258

Chronic Obstructive Pulmonary Disease (COPD)

View study

RECRUITINGNA

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

NCT06891755

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 13, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Home Pulmonary Rehabilitation for COPD

Inclusion Criteria

Exclusion Criteria

cfMSC Stem Cell Therapy Targeting COPD

A Clinical Study of Inhaled Nitric Oxide in Patients With Chronic Obstructive Pulmonary Disease

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Mindful-Breath for People With COPD

The HELlenic Thoracic Society Initiative for CΟPD and CVD

Exploring Novel Biomarkers for Emphysema Detection